Publications by authors named "Thomas DiPetrillo"

Claim this Profile
C
Clinicopathological and molecular analysis of a dermatofibrosarcoma protuberans with fibrosarcomatous transformation in the breast.
Liu Liu, Don Dizon, Thomas A DiPetrillo, Jesse Hart, Liang Cheng

NPJ Precis Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRAIL agonists rescue mice from radiation-induced lung, skin, or esophageal injury.
Jillian Strandberg, Anna Louie, Seulki Lee, Marina Hahn, Praveen Srinivasan, Thomas A DiPetrillo

J Clin Invest· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial of Five-Fraction Accelerated Partial Breast Irradiation Using Noninvasive Image-Guided Breast Brachytherapy.
Jaroslaw T Hepel, Kara L Leonard, Catheryn M Yashar, John P Einck, Sandra J Sha, Thomas A DiPetrillo

Int J Radiat Oncol Biol Phys· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848.
Leila T Tchelebi, Kathryn A Winter, Ross A Abrams, Howard P Safran, William F Regine, Thomas A DiPetrillo

Int J Radiat Oncol Biol Phys· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative Durvalumab.
Brett H Diamond, Neel Belani, Rebecca Masel, Kathryn DeCarli, Thomas DiPetrillo

Adv Radiat Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Brown University Oncology Group Experience With FOLFOX + Nab-paclitaxel [FOLFOX-A] for Metastatic and Locally Advanced Pancreatic, BrUOG-292 and BrUOG-318.
Rimini Breakstone, Khaldoun Almhanna, Alexander Raufi, Rachel E Beard, Kara-Lynne Leonard, Thomas Dipetrillo

Am J Clin Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial.
Howard P Safran, Kathryn Winter, David H Ilson, Dennis Wigle, Thomas DiPetrillo

Lancet Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Veliparib in combination with carboplatin/paclitaxel-based chemoradiotherapy in patients with stage III non-small cell lung cancer.
David E Kozono, Thomas E Stinchcombe, Joseph K Salama, Jeffrey Bogart, W Jeffrey Petty, Thomas A DiPetrillo

Lung Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Diabetes and Insulin Use on Prognosis in Patients With Resected Pancreatic Cancer: An Ancillary Analysis of NRG Oncology RTOG 9704.
Danielle S Bitterman, Kathryn A Winter, Theodore S Hong, Charles S Fuchs, William F Regine, Thomas DiPetrillo

Int J Radiat Oncol Biol Phys· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Cancer Therapeutics and Their Complications: A Primer for the Primary Care Provider.
Zachary Brownlee, Andre De Souza, Paul P Koffer, Thomas A DiPetrillo, Anthony E Mega

R I Med J (2013)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial.
Ross A Abrams, Kathryn A Winter, Howard Safran, Karyn A Goodman, William F Regine, Thomas A DiPetrillo

Am J Clin Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704.
Marsha Reyngold, Kathryn A Winter, William F Regine, Ross A Abrams, Howard Safran, Thomas DiPetrillo

Oncologist· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I and Pharmacology Study of Ropidoxuridine (IPdR) as Prodrug for Iododeoxyuridine-Mediated Tumor Radiosensitization in Advanced GI Cancer Undergoing Radiation.
Timothy Kinsella, Howard Safran, Susan Wiersma, Thomas DiPetrillo, Andrew Schumacher

Clin Cancer Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five fraction accelerated partial breast irradiation using noninvasive image-guided breast brachytherapy: Feasibility and acute toxicity.
Jaroslaw T Hepel, Catheryn Yashar, Kara L Leonard, John P Einck, Sandra Sha, Thomas DiPetrillo

Brachytherapy· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability of ADXS11-001 Lm-LLO Listeria-Based Immunotherapy With Mitomycin, Fluorouracil, and Radiation for Anal Cancer.
Howard Safran, Kara-Lynne Leonard, Kimberly Perez, Matthew Vrees, Adam Klipfel, Thomas A DiPetrillo

Int J Radiat Oncol Biol Phys· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704.
Yaacov R Lawrence, Jennifer Moughan, Anthony M Magliocco, Alexander C Klimowicz, William F Regine, Thomas A DiPetrillo

Cancer· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704.
William F Regine, Kathryn Winter, Ross A Abrams, Howard Safran, Ivan L Kessel, Thomas A DiPetrillo

Adv Radiat Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Outcomes Using Hypofractionated Tumor Bed Boost Combined With Hypofractionated Whole Breast Irradiation for Early-stage Breast Cancer.
Esther Yu, David Huang, Kara Leonard, Thomas Dipetrillo, David Wazer

Clin Breast Cancer· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with Long-Term Control of Systemic Disease Are a Favorable Prognostic Group for Treatment of Brain Metastases with Stereotactic Radiosurgery Alone.
Daniel K Ebner, Daniel Gorovets, Paul Rava, Deus Cielo, Timothy J Kinsella, Thomas A DiPetrillo

World Neurosurg· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation Study.
Jaroslaw T Hepel, Kara Lynne Leonard, Howard Safran, Thomas Ng, Angela Taber, Thomas DiPetrillo

Int J Radiat Oncol Biol Phys· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, Treatment, and Survival Patterns for Sacral Chordoma in the United States, 1974-2011.
Esther Yu, Paul P Koffer, Thomas A DiPetrillo, Timothy J Kinsella

Front Oncol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management approach for recurrent brain metastases following upfront radiosurgery may affect risk of subsequent radiation necrosis.
Ali Rae, Daniel Gorovets, Paul Rava, Daniel Ebner, Deus Cielo, Thomas A DiPetrillo

Adv Radiat Oncol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Sublobar Resection on Pulmonary Function: Long-Term Results from American College of Surgeons Oncology Group Z4032 (Alliance).
Michael S Kent, Sumithra J Mandrekar, Rodney Landreneau, Francis Nichols, Thomas A DiPetrillo

Ann Thorac Surg· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032).
Michael S Kent, Sumithra J Mandrekar, Rodney Landreneau, Francis Nichols, Nathan R Foster, Thomas A DiPetrillo

Ann Thorac Surg· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and safety of cavity-directed stereotactic radiosurgery for brain metastases at a high-volume medical center.
Paul Rava, Jennifer Rosenberg, Daniel Jamorabo, Shirin Sioshansi, Thomas DiPetrillo

Adv Radiat Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis